|
Market Closed -
Nasdaq
01:30:00 03/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 144.74 USD | -1.87% |
|
-4.10% | +17.92% |
| 02/10 | Legend Biotech Faces Pressure From Rivals Ahead of Key FDA Decision, UBS Says | MT |
| 28/09 | Mirum's liver infection drug lowers virus levels in late-stage study | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 18TCr | - | ||||
| 1,01900Cr | |||||
| 62TCr | - | ||||
| 46TCr | |||||
| 36TCr | |||||
| 33TCr |
- Stock Market
- Stocks
- GILD Stock
- Charts Gilead Sciences, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
